The cross talk of the NR4A1–NR4A3 subfamily members with various oncogene and tumor suppressor pathways is well-established (Safe et al., 2014; Beard et al., 2015; Wan et al., 2020). The gene discussed is NR4A3; the disease is neoplasm.